Home › NDC Lookup › Ingredients › Sennosides And Docusate Sodium › 60687-0622-01
Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet, 100-count — NDC 60687-0622-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet, 100-count — NDC 60687-622-01 (Billing 60687-0622-01)

by American Health Packaging · 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK

This is a package of 100 tablets of Sennosides and Docusate Sodium 8.6 mg; 50 mg Tablet from American Health Packaging, marketed since Aug 2021 and currently FDA-listed; retail pharmacies pay about $0.0297 per tablet (NADAC). It is this product's only package size.

NDC 60687-0622-01
🏷️ FDA NDC (as labeled) 60687-622-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 60687-622-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
60687 labeler · 622 product · 01 package
Package marketed since
Aug 3, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 6068762201 9
Medicaid fills, this package
780 prescriptions in the last four reported quarters
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 60687-622-01
Product NDC 60687-622
11-digit billing NDC 60687062201
NCPDP billing unit EA — each (per item)
RxCUI 998740
UNII 3FYP5M0IJX, F05Q2T2JA0
Application # M007
SPL Set ID 4b84d5d7-43cf-47bb-af59-088550c3a0bc
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-08-03
Route ORAL
Dosage form TABLET
Substance SENNOSIDES; DOCUSATE SODIUM

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46991002770320
GPI class Sennosides-Docusate Sodium
GCN Seq No 048044
GCN 13483
HICL code 021772
Ingredient (HICL) Sennosides/Docusate Sodium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name SENNOSIDES-DOCUSATE SODIUM TAB
FDB brand name Sennosides-Docusate Sodium
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 048044
  • GCN: 13483
  • GPI-14 (Medi-Span): 46991002770320
  • HICL (First Databank): 021772
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 998740
Why two NDCs? The FDA registers this code as 60687-622-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 60687-0622-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SENNOSIDES-DOCUSATE SODIUM TAB Ingredient Sennosides/Docusate Sodium
🧪 What is this product?

This is an oral tablet that combines two active ingredients commonly used together to address constipation. Sennosides are a natural laxative derived from senna plants that work by stimulating bowel movement. Docusate sodium is a stool softener that helps make bowel movements easier by drawing water into the stool. This combination product is marketed as an over-the-counter monograph drug, meaning it follows FDA's established guidelines for this category of laxative products.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.030 $2.97 / 100 tablet
Medicaid paysCMS SDUD · 12 mo $0.1996 $19.96 / 100 tablet
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.034 $0.023
▼ Down 4% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
60687-0622-01 You're viewing this Main listing 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK 2021-08-03 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senexon-S 8.6 mg/1; 50 mg 00536-1247-01 RUGBY 100 tablets $0.030 — Availability likely —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 00536-1248-01 RUGBY 100 tablets $0.030 — Availability likely —
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 00904-7440-61 Major 10 tablets $0.030 — Availability likely —
Senna Plus 50 mg/1; 8.6 mg 46122-0625-72 AmerisourceBergen 60 tablets $0.030 — Availability likely —
Stool Softener Laxative 50 mg/1; 8.6 mg 46122-0669-78 AmerisourceBergen 100 tablets $0.030 — Availability likely —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mgthis 60687-0622-01 American 100 tablets $0.030 — Availability likely —
Senna Plus 8.6 mg/1; 50 mg 70000-0520-01 CARDINAL 30 tablets $0.030 — Availability likely —
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 70000-0526-01 CARDINAL 100 tablets $0.030 — Availability likely —
Senna-S 8.6 mg/1; 50 mg 70677-1069-01 STRATEGIC 60 tablets $0.030 — Availability likely —
Stool Softener 50 mg/1; 8.6 mg 70677-1094-01 Strategic 100 tablets $0.030 — Availability likely —
Senna S 50 mg/1; 8.6 mg 83324-0135-60 QUALITY 60 tablets $0.030 — Availability likely —
Stool Softener 50 mg/1; 8.6 mg 83324-0136-01 QUALITY 100 tablets $0.030 — Availability likely —
Senna-S 50 mg/1; 8.6 mg 70677-1246-01 Strategic 100 tablets $0.032 — FDA listed +7%
Colace 50 mg/1; 8.6 mg 67618-0110-10 Atlantis 5 tablets $0.412 — Availability likely +1287%
Senokot-S 8.6 mg/1; 50 mg 67618-0310-01 Atlantis 10 tablets $0.412 — Availability likely +1287%
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 00363-0827-20 Walgreens 200 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 00363-0883-12 Walgreens 120 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8550-20 Walgreens 200 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8780-20 Walgreens 200 tablets — — Discontinued —
Senexon-S 8.6 mg/1; 50 mg 00615-8331-39 NCS 30 tablets — — FDA listed —
Senna-S Laxative With Stool Softener 50 mg/1; 8.6 mg 00761-0910-02 Basic 100 tablets — — FDA listed —
Senna S 8.6 mg/1; 50 mg 10135-0669-01 Marlex 100 tablets — — FDA listed —
Stool Softening Senna Laxative 50 mg/1; 8.6 mg 11673-0192-03 TARGET 30 tablets — — FDA listed —
Stool Softener And Stimulant Laxative 8.6 mg/1; 50 mg 11673-0209-01 TARGET 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 16103-0378-07 Pharbest 60 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 17856-1248-01 ATLANTIC 1 tablet — — FDA listed —
Natural Vegetable Laxative and Stool Softener 50 mg/1; 8.6 mg 21130-0219-03 BETTER 30 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0829-20 Safeway, 200 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 21130-0855-20 Safeway, 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0878-20 Safeway, 200 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 21130-0883-30 Safeway, 30 tablets — — FDA listed —
Stool Softener 8.6 mg/1; 50 mg 21130-0902-20 BETTER 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 36800-0084-01 TOP 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 36800-0783-12 TOP 120 tablets — — FDA listed —
Laxative Docusate Sodium with Senna 50 mg/1; 8.6 mg 36800-0861-01 TOPCO 100 tablets — — FDA listed —
Vegetable Laxative and Stool Softner 50 mg/1; 8.6 mg 36800-0938-60 TOPCO 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0355-12 H 120 tablets — — FDA listed —
Stool Softener and Stimulant Laxative 50 mg/1; 8.6 mg 37808-0549-29 H-E-B 240 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0878-12 H 120 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 41163-0755-10 United 100 tablets — — FDA listed —
Stool Softener Plus Stimulant 50 mg/1; 8.6 mg 41163-0778-10 United 100 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 41163-0829-10 United 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 41163-0883-30 United 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 41226-0192-06 KROGER 60 tablets — — FDA listed —
Stool Softener-Stimulant Laxative 8.6 mg/1; 50 mg 41226-0209-06 Kroger 60 tablets — — FDA listed —
Sool Softener Laxative 50 mg/1; 8.6 mg 49035-0270-30 EQUATE 30 tablets — — FDA listed —
Laxative and Stool Softener 50 mg/1; 8.6 mg 49035-0360-30 EQUATE 30 tablets — — FDA listed —
Senna Time S 50 mg/1; 8.6 min 49483-0081-00 TIME 100000 tablets — — FDA listed —
Sennosides And Docusate Sodium 8.6 mg/1; 50 mg 49483-0097-00 TIME 100000 tablets — — FDA listed —
Laxacin 50 mg/1; 8.6 mg 50488-0901-01 Alexso, 100 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 50804-0304-10 GOOD 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 50804-0855-10 Good 100 tablets — — Discontinued —
Senna S 50 mg/1; 8.6 mg 53329-0989-62 Medline 60 tablets — — FDA listed —
Drug Mart Vegetable Laxative plus Stool Softener 50 mg/1; 8.6 mg 53943-0153-01 Discount 100 tablets — — FDA listed —
Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1; 8.6 mg 53943-0154-01 Discount 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 54257-0089-02 Magno-Humphries, 100 tablets — — FDA listed —
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 55154-0195-00 Cardinal 10 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 55154-2578-00 Cardinal 10 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 55319-0565-10 Family 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0829-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0855-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0978-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener with Laxative 8.6 mg/1; 50 mg 57896-0304-01 Geri-Care 100 tablets — — FDA listed —
Senna Plus 8.6 mg/1; 50 mg 57896-0458-10 Geri-Care 1000 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 57896-0555-01 Geri-Care 100 tablets — — FDA listed —
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0855-10 P 100 tablets — — FDA listed —
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0878-10 P 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 62011-0417-01 Strategic 100 tablets — — Discontinued —
Docusate Sodium and Sennosides 50 mg/1; 8.6 mg 62993-0002-01 Morepen 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 63561-0187-01 Granulation 100 tablets — — FDA listed —
Stool Softener Stimulant laxative 50 mg/1; 8.6 mg 63868-0875-01 QUALITY 100 tablets — — FDA listed —
Stool Softener plus Laxative 50 mg/1; 8.6 mg 63868-0878-60 QUALITY 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0884-01 QUALITY 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0946-01 QUALITY 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0855-10 Best 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0878-10 Best 100 tablets — — FDA listed —
Stool Softener with laxative 50 mg/1; 8.6 mg 67091-0328-60 WinCo 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 67091-0373-60 WinCo 60 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 68788-7674-01 Preferred 100 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 68788-8780-01 Preferred 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 69517-0131-02 HealthLife 2 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 69618-0065-01 Reliable-1 100 tablets — — FDA listed —
Colon Detox 50 mg/1; 8.6 mg 69729-0151-60 OPMX 60 tablets — — FDA listed —
Laxative Stool Softener 50 mg/1; 8.6 mg 69842-0776-18 CVS 180 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0881-10 CVS 100 tablets — — FDA listed —
Senna Plus 50 mg/1; 8.6 mg 69842-0883-18 CVS 180 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0887-10 CVS 100 tablets — — FDA listed —
Docuzen 8.6 mg/1; 50 mg 71205-0282-30 Proficient 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 71205-0970-00 Proficient 100 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 71335-1674-01 Bryant 30 tablets — — FDA listed —
Stool Softener with Laxative 8.6 mg/1; 50 mg 71335-2522-01 Bryant 30 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 71335-2693-01 Bryant 30 tablets — — FDA listed —
Docuzen 8.6 mg/1; 50 mg 71574-0700-60 Village 60 tablets — — FDA listed —
Senna-S 50 mg/1; 8.6 mg 72090-0030-20 Pioneer 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0855-10 Care 100 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0878-10 Care 100 tablets — — FDA listed —
Senna S Orange 50 mg/1; 8.6 mg 72476-0883-60 Care 60 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 73057-0378-07 Ulai 60 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 76420-0918-01 Asclemed 100 tablets — — FDA listed —
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 79481-0304-01 Meijer, 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 79481-0555-06 Meijer, 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 79903-0009-12 WALMART 120 tablets — — FDA listed —
Senna-Plus 50 mg/1; 8.6 mg 80136-0555-01 Heartland 100 tablets — — Discontinued —
Laxacin 50 mg/1; 8.6 mg 80425-0345-01 Advanced 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 80513-0105-25 Advanced 250 tablets — — FDA listed —
Senna With Docusate Sodium 8.6 mg/1; 50 mg 83586-0001-00 HHH 50000 tablets — — FDA listed —
Senna-S 50 mg/1; 8.6 mg 84324-0013-01 NUVICARE 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 85111-0455-10 RMT 1000 tablets — — FDA listed —
Healix Senna-S 8.6 mg/1; 50 mg 87275-2451-01 Brainstorm 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Aug 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6 lake, hypromellose, magnesium stearate, PEG, silica, talc, titanium dioxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerican Health Packaging
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code60687
First marketedAug 2021
Product typeHuman Otc Drug
Portfolio674 products on file

More NDCs from American Health Packaging labeler code 60687

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 17 words ▾

Uses relieves occasional constipation (irregularity) this product generally produces a bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 58 words ▾

Directions do not exceed 8 tablets in 24 hours Adults and children 12 years of age and older take 2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor; the maximum dose should be 4 tablets in the morning and 4 tablets at bedtime Children under 12 years ask a doctor

⚠️ Warnings 113 words ▾

Warnings Do not use if you are now taking mineral oil, unless directed by a doctor laxative products for longer than 1 week unless directed by a doctor Ask a doctor before use if you have stomach pain, nausea or vomiting noticed a sudden change in bowel habits that lasts over two weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 35 words ▾

Other information each tablet contains: calcium 20 mg, sodium 3 mg. Very low sodium. store at 20°-25°C (68°-77°F); excursions permitted between 15°-30°C (59°-86°F). FOR YOUR PROTECTION: Do not use if blister is torn or broken.

🧪 Active Ingredient 12 words ▾

Active ingredients (in each tablet) Docusate Sodium 50 mg Sennosides 8.6 mg

🧪 Inactive Ingredients 19 words ▾

Inactive ingredients cellulose, croscarmellose sodium, dicalcium phosphate, FD&C yellow #6 lake, hypromellose, magnesium stearate, PEG, silica, talc, titanium dioxide.

🎯 Purpose 4 words ▾

Purpose Stool softener Laxative

📄 Ask a Doctor Before Use If 25 words ▾

Ask a doctor before use if you have stomach pain, nausea or vomiting noticed a sudden change in bowel habits that lasts over two weeks

📄 Stop Use and Ask a Doctor If 29 words ▾

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 111 words ▾

Package/Label Display Panel – Carton – 8.6 mg/50 mg NDC 60687- 622 -01 Sennosides and Docusate Sodium Tablets Natural Vegetable Laxative with Stool Softener 8.6 mg/50 mg 100 Tablets (10 x 10) Drug Facts Active ingredients (in each tablet)......................................................................Purpose Docusate Sodium 50 mg...............................................................................Stool softener Sennosides 8.6 mg...............................................................................................

Laxative The drug product contained in this package is from NDC # 57896-555, Geri-Care Pharmaceuticals Corp. Product of India Distributed by: American Health Packaging, Columbus, Ohio 43217 762201 0462201/0825 8.6 mg 50mg Sennosides DSS Tablets Carton

Package/Label Display Panel – Blister – 8.6 mg/50 mg Sennosides and Docusate Sodium Tablet Laxative/Stool Softener 8.6 mg/50 mg 8.6 mg/50 mg Sennosides and Docusate Sodium Tablet Blister

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
780
Units reimbursed last 4 qtrs
22.4K
Gross reimbursed last 4 qtrs
$4.5K
Avg / prescription
$5.74
Avg / unit
$0.1996
Latest quarter Q4 2025
184Rx
Medicaid pays / ea
$0.1996
gross reimbursed
vs
NADAC / ea
$0.0297
acquisition cost
=
Spread
+$0.1699
+572% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
52% FFS 48% MCO
Fee-for-service · 404 Rx Managed care · 376 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 1,420 units · 24.8 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 12,859 units · 65.7 per 100k residents NY Vermont: no data reported VT New Hampshire: 79 units · 5.6 per 100k residents NH Oregon: no data reported OR Nevada: 570 units · 17.8 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 612 units · 5.2 per 100k residents OH Pennsylvania: 4,936 units · 38.1 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 119 units · 0.3 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 744 units · 12.0 per 100k residents MO Kentucky: 1,103 units · 24.4 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.365.7
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 65.7 /100k
2 Pennsylvania 38.1 /100k
3 Minnesota 24.8 /100k
4 Kentucky 24.4 /100k
5 Nevada 17.8 /100k
6 Missouri 12.0 /100k
7 New Hampshire 5.6 /100k
8 Ohio 5.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for SENNOSIDES AND DOCUSATE SODIUM — the ingredient across all brands.

Top reported reactions

Fatigue283
Nausea226
Death208
Dyspnoea179
Diarrhoea171
Fall165
Constipation161

Age at onset

Child5
Adolescent7
Adult170
Elderly231

Reporter sex

2,846 reports
Male · 40%
Female · 60%

Serious outcomes

Hospitalization1,137
Death401
Life-threatening61
Disabling45
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 308 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 60687-0620-01 · American 60687-0623-01 · American →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.